Janssen Diagnostics to Present at the Biomarker World Congress on Next Generation Sequencing of Circulating Tumor Cells from the CELLSEARCH(R) System

RARITAN, NJ / ACCESSWIRE / April 28, 2015 / Janssen Diagnostics, a precision
diagnostics company committed to providing technologies that help
improve patient outcomes, announced that Dr. Charles Saginario, Principal Scientist at Janssen Diagnostics, is scheduled to present at the Biomarker World Congress 2015. The event is taking place at the Loews Philadelphia Hotel in Philadelphia, PA.

The presentation is entitled, “Next Generation Sequencing of Circulating Tumor Cells from the CELLSEARCH(R) System.”

The Details of the presentation are as follows:

Date: Tuesday, May 5th
Track: Cell-Free Biomarkers and Diagnostics
Time: 4:35 PM Eastern

About Janssen Diagnostics

At Janssen Diagnostics we are
passionate about the promise of personalized medicine and its potential
to improve outcomes for specific patients through targeted therapies.

We aspire to help doctors and researchers better identify, prevent or
intervene earlier with diseases, or cure people with the right
medicines for the right person, at the right time.

Being part of Janssen puts us in a strong position, enabling us to bridge Janssen’s
extensive pharmaceutical knowledge-base and global capabilities, with
our own heritage and talent in research technology, diagnostics and
health information technology to deliver integrated solutions into the
hands of healthcare providers.

What makes Janssen Diagnostics unique is the concentration of minds, personnel and skills at the heart of Pharma
R&D, specifically organized to develop and commercialize products
and services around meeting patient needs of both today and tomorrow.

To speak with Dr. Saginario or learn more about Janssen Diagnostics, please contact:

Frederik Wittock
Janssen Global Services, LLC
fwittock@its.jnj.com or +32 14 60 57 24

Scott Canady
scanady2@its.jnj.com or 809-481-3790

SOURCE: Janssen Diagnostics

ReleaseID: 428286